Abstract
Backgound
Patients with essential hypertension had a higher recurrence rate of atrial fibrillation (AF) than patients without hypertension. This study evaluated the role of various parameters for predicting recurrence after conversion of AF in patients with essential hypertension.
Methods
We retrospectively analyzed 136 patients with essential hypertension and a known history of AF. P‐wave duration and dispersion were measured in a 12‐lead electrocardiograph. The size and function of the left atrium (LA) and left atrial appendage (LAA) were assessed by transthoracic and transesophageal echocardiography. The time interval from initiation of P‐wave to the start of LAA ejection flow (P‐LAA) was measured at the same time. All the patients were followed up for a period of 12 ± 6 months for the recurrence of AF.
Results
In the follow‐up period, 38.2%of patients underwent AF recurrence. Age, P‐LAA, Pmax, P‐wave dispersion, left atrium diameter (LAD), and maximum and minimum LAA volume were significantly higher in patients with AF recurrence than in patients without AF recurrence, while EF‐LAA and LAA peak emptying velocity were much lower in patients with AF recurrence. P‐LAA had positive correlation with LAD and P‐wave dispersion (r = 0.501, p < 0.0001; r = 0.713, p < 0.0001).
Conclusion
These results indicated that increased P‐wave dispersion, P‐LAA in addition to the dilated LA, and the depressed LAA function may be useful to identify patients with hypertension at risk of recurrent AF. Copyright © 2009 Wiley Periodicals, Inc.
Keywords: hypertension, arrhythmia, echocardiography
Full Text
The Full Text of this article is available as a PDF (216.2 KB).
References
- 1. Sundstrom J, Sullivan L, D'Agostino RB, Jacques PF, Selhub J, et al.: Plasma homocysteine, hypertension incidence, and blood pressure tracking: The Framingham Heart Study. Hypertension 2003; 42: 1100–1105. [DOI] [PubMed] [Google Scholar]
- 2. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow‐Up Study. Am J Med 1995; 98: 476–484. [DOI] [PubMed] [Google Scholar]
- 3. Zapolski T, Wysokinski A: Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation. Kardiol Pol 2005; 63: 254–262. [PubMed] [Google Scholar]
- 4. Savelieva I, Camm J: Update on atrial fibrillation: Part I. Clin Cardiol 2008; 31: 55–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Donal E, Herpin D: Atrial remodeling, systemic hypertension, stroke. Arch Mal Coeur Vaiss 2005; 98: 53–57. [PubMed] [Google Scholar]
- 6. Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S, et al.: Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Cardiovasc Surg 2004; 127: 770–778. [DOI] [PubMed] [Google Scholar]
- 7. Boriani G, Diemberger I, Biffi M, Camanini C, Valzania C, et al.: P wave dispersion and short‐term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol 2005; 101: 355–361. [DOI] [PubMed] [Google Scholar]
- 8. Yilmaz R, Demirbag R: P‐wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 2005; 38: 279–284. [DOI] [PubMed] [Google Scholar]
- 9. Celik T, Iyisoy A, Kursaklioglu H, Yilmaz MI, Kose S, et al.: The comparative effects of telmisartan and ramipril on P‐wave dispersion in hypertensive patients: A randomized clinical study. Clin Cardiol 2005; 28: 298–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, et al.; ACUTE Investigators: Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005; 96: 935–941. [DOI] [PubMed] [Google Scholar]
- 11. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H: Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow‐up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 1807–1812. [DOI] [PubMed] [Google Scholar]
- 12. Srichai MB, Griffin B, Banbury M, Sabik EM: Images in cardiovascular medicine. Inverted left atrial appendage ligation mimicking thrombus. Circulation 2005; 111: e178–e179. [DOI] [PubMed] [Google Scholar]
- 13. Lloyd‐Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, et al.: Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004; 110: 1042–1046. [DOI] [PubMed] [Google Scholar]
- 14. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, et al.: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74: 236–241. [DOI] [PubMed] [Google Scholar]
- 15. Donal E, Yamada H, Leclercq C, Herpin D: The left atrial appendage, a small, blind‐ended structure: A review of its echocardiographic evaluation and its clinical role. Chest 2005; 128: 1853–1862. [DOI] [PubMed] [Google Scholar]
- 16. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, et al.: Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation 2005; 112: 1266–1273. [DOI] [PubMed] [Google Scholar]
- 17. Barbato G, Carinci V, Pergolini F, Di Pasquale G: Percutaneous occlusion of the left atrial appendage for systemic embolism prevention in patients with atrial fibrillation: state of the art and report of two cases. Ital Heart J 2005; 6: 409–413. [PubMed] [Google Scholar]
- 18. Dogan A, Kahraman H, Ozturk M, Avsar A: P wave dispersion and left atrial appendage function for predicting recurrence after conversion of atrial fibrillation and relation of p wave dispersion to appendage function. Echocardiography 2004; 21 523–530. [DOI] [PubMed] [Google Scholar]
- 19. Kinay O, Nazli C, Ergene O, Dogan A, Gedikli O, et al.: Time interval from the initiation of the electrocardiographic P wave to the start of left atrial appendage ejection flow: A novel method for predicting atrial fibrillation recurrence. J Am Soc Echocardiogr 2002; 15: 1479–1484. [DOI] [PubMed] [Google Scholar]
- 20. Weiss JN, Qu Z, Chen PS, Lin SF, Karagueuzian HS, et al.: The dynamics of cardiac fibrillation. Circulation 2005; 112: 1232–1240. [DOI] [PubMed] [Google Scholar]
- 21. O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ Jr, Philippon F, et al.; AFFIRM Investigators: Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow‐up Investigation of Rhythm Management [AFFIRM] database). Am J Cardiol 2005; 96: 815–821. [DOI] [PubMed] [Google Scholar]
- 22. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, et al.: Tachycardia‐related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000; 75: 790–795. [DOI] [PubMed] [Google Scholar]